Article: Dysport vs Botox Units: A Practical Conversion Guide
Dysport vs Botox Units: A Practical Conversion Guide
The most popular advice about Dysport vs Botox units is also the most misleading: divide or multiply by one simple ratio, then treat the result as interchangeable. Fifty Dysport units are not equivalent to fifty Botox units, because each product uses its own potency scale. The number on the syringe tells you which product was used, not a universal amount of botulinum toxin shared across brands.
A safer comparison looks at clinical effect, diffusion, concentration, muscle strength, injection technique, and the area being treated. Published reviews support a practical Dysport-to-Botox range rather than a fixed conversion, while product labeling makes clear that the units aren't directly interchangeable across formulations (clinical review of conversion ratios).
This guide translates that evidence into practical decisions. You'll see how to interpret conversion ranges, visualize starting doses for common facial areas, understand why spread matters, compare treatment costs without being fooled by per-unit pricing, and choose the product based on your anatomy rather than a chart found online.
Why the Unit Numbers Are Not What You Think
A unit isn't a gram, milligram, or universal measurement. It's a product-specific biological potency unit, calibrated against that manufacturer's reference standard. Botox and Dysport therefore use different numerical systems, so placing the same number of units from each product side by side creates a false comparison.
A 2004 pharmacokinetic review described one Botox unit as roughly equivalent to three Dysport units in clinically observable activity. Later reviews found published ratios ranging from 6:1 to 1:1, with more recent clinical literature generally supporting approximately 2 to 4 Dysport units for each Botox unit. Some evidence suggests ratios below 3:1 may be more appropriate in particular situations.
Why online comparisons go wrong
Patients often encounter unit numbers beside per-vial prices, promotional offers, or forum anecdotes. That presentation makes Dysport appear dramatically cheaper when its dose usually requires more numerical units. A clinic charging less per Dysport unit may still charge a similar amount for the same treated area after the injector accounts for potency and the planned spread.
Practical rule: Never compare a Botox price per unit with a Dysport price per unit until you know the estimated dose for your specific area.
The useful questions are different. Ask how much product your anatomy needs, where the injector plans to place it, how broadly it should spread, and what result the dose is intended to create. A broad forehead and a small muscle beside the eye shouldn't be evaluated with the same arithmetic.
The sections below use the clinically supported range as a guide, not a prescription. They also address onset, duration, diffusion, area-based pricing, and why an experienced injector may intentionally choose a ratio that differs from a chart.
What Dysport and Botox Actually Are
Raw unit counts are not interchangeable because Dysport and Botox are different botulinum toxin type A formulations. Dysport, or abobotulinumtoxinA, and Botox, or onabotulinumtoxinA, temporarily reduce muscle contraction by limiting acetylcholine release at the neuromuscular junction. Less forceful contraction can soften dynamic lines caused by repeated facial movement.
The shared mechanism does not create a shared measuring scale. A pharmacology review reports specific potency of approximately 154 units per nanogram for Dysport and 137 units per nanogram for Botox, helping explain why the labels cannot be compared like identical units (comparative pharmacology review). The result also depends on concentration, injection placement, the size and strength of the muscle, and the amount of spread the treatment area can tolerate.
Dysport is supplied in 300-unit or 500-unit vials. Its FDA labeling requires reconstitution with preservative-free 0.9% sodium chloride injection before use (FDA Dysport prescribing information). Botox has its own labeled vial strengths and unit system. Vial size and dilution affect preparation, concentration, and handling, but they do not turn the products into a common unit scale.
A practical comparison
| Attribute | Dysport (abobotulinumtoxinA) | Botox (onabotulinumtoxinA) |
|---|---|---|
| Active type | Botulinum toxin type A | Botulinum toxin type A |
| Unit system | Product-specific Dysport units | Product-specific Botox units |
| Clinical planning | Dose is adjusted for the muscle, area, concentration, and desired spread | Dose is adjusted for the muscle, area, concentration, and desired spread |
| Available vial information | 300-unit or 500-unit vials | Product labeling defines its own vial strengths |
| Preparation | Reconstituted with preservative-free 0.9% sodium chloride injection | Prepared according to its own product labeling |
| Core clinical action | Temporarily reduces acetylcholine release at the neuromuscular junction | Temporarily reduces acetylcholine release at the neuromuscular junction |
| Main practical distinction | Broader spread may help in a wide treatment area or create a risk near structures that require precision | More localized behavior may support precision in smaller treatment zones |
A vial number only has meaning within its own product. Compare the planned dose, concentration, injection pattern, muscle behavior, and intended result rather than the printed units alone.
Conversion Ratios Supported by Evidence
A Dysport-to-Botox conversion is a clinical estimate, not a universal formula. The most defensible working range is approximately 2:1 to 3:1, with 2.5:1 often used as a midpoint. Published comparisons have reported ratios from 1:1 to 6:1, which is why a fixed online chart can create false precision (review of conversion evidence).
A double-blind randomized cervical dystonia study examined a 3:1 Dysport-to-Botox hypothesis. Patients received either the clinically indicated Botox dose or three times that dose in Dysport units, with similar improvement and no significant difference in safety profiles (randomized cervical dystonia study). This supports 3:1 as a useful clinical reference. It does not make 3:1 interchangeable across every facial muscle or treatment plan.
How clinicians apply the range
| Conversion Ratio (Dysport:Botox) | Clinical Context | When It Is the Right Anchor |
|---|---|---|
| 2:1 | Broad treatment planning or matching a known prior response | Useful when translating a successful Botox result across a wider area |
| 2.5:1 | Practical midpoint supported by comparative clinical experience | A reasonable starting reference when the goal is clear but product-specific history is limited |
| 3:1 | More cautious equivalence estimate for smaller or sensitive zones | Appropriate when precision matters, especially near small muscles or during a first Dysport treatment |
| Up to 4:1 | Specific settings reported in the literature | Requires individualized clinical reasoning rather than automatic use |
The ratio changes with muscle mass, injection depth, dilution, concentration, technique, and desired spread. These factors affect how much product reaches the target muscle and how widely the effect appears. A broad frontalis treatment may call for a lower conversion anchor when the goal is even softening across a large surface. A small orbicularis oculi treatment demands tighter control, so dose and placement may follow a different strategy.
The unit ratio is only one part of the decision. Muscle behavior and concentration often explain why two plans with mathematically similar doses produce different results.
The clinical decision
For full-face planning, or for a patient with a well-documented Botox response, 2:1 can be a reasonable initial anchor before adjusting for anatomy and movement. For small precision areas, including the orbicularis oculi, or for a first Dysport session, 3:1 may offer a more cautious reference point. The final choice still depends on examination of muscle activity, brow balance, treatment goals, and the intended degree of spread.
The correct conversion reproduces the intended clinical effect safely. It is not necessarily the ratio that makes the arithmetic look neat.
Example Unit Dosing for Common Treatment Areas
Patients usually want to know what the numbers look like on an actual treatment plan. The ranges below are approximate starting points for an average adult with moderate muscle strength, not prescriptions. A qualified injector should assess movement, brow position, facial asymmetry, muscle thickness, and the patient's preferred level of expression before selecting a dose.
| Treatment Area | Botox Units | Dysport Units (approx.) | Notes |
|---|---|---|---|
| Glabellar lines, the “11s” | 10 to 20 | 30 to 60 | Strong corrugator activity may require the higher end |
| Forehead, frontalis | 6 to 15 across the area | 20 to 45 across the area | Conservative placement helps protect brow position |
| Crow's feet, orbicularis oculi | 6 to 15 per side | 18 to 45 per side | Precision matters because the muscle is thin and close to the eye |
How to interpret the ranges
Start with the treatment goal, not the biggest number. Someone seeking softened movement may sit near the lower end, while a patient with strong muscle activity or a preference for a more immobilized appearance may need more. Men and patients with stronger frontalis or masseter activity often require individualized adjustments, but the injector should still balance treatment against the risk of heaviness or functional changes.
A forehead plan deserves special caution. The frontalis helps lift the brows, so treating it without considering the glabella and existing brow position can create an unwanted heavy appearance. More product isn't automatically a smoother or better result.
Dose is only one part of the treatment. Injection depth, spacing, dilution, and the muscle's behavior determine how those units translate into movement reduction.
Bunny lines, a lip flip, the depressor anguli oris, chin dimpling, and masseter treatment for bruxism follow the same product-specific logic. They aren't included in the core table because each involves different anatomy and a different tolerance for diffusion. For more detail on lateral eye treatment planning, see Botox units for crow's feet.
Onset, Duration, and Diffusion Compared
Unit conversion cannot predict the patient's timeline by itself. Onset, visible movement reduction, and how long the result lasts depend on the product, injection plan, muscle strength, treatment area, and the patient's response. Dysport is often perceived as starting sooner, while Botox may appear more gradual. The difference is useful for scheduling, but it is not a guarantee.
Plan around the appointment date and the event date. Allow time for the effect to develop, then assess the result before deciding whether any adjustment is appropriate. A patient who has responded quickly to one product may not experience the same timing after changing products or treatment areas.
What patients notice in practice
| Characteristic | Dysport | Botox | Practical implication |
|---|---|---|---|
| Onset | Often perceived as faster | Often perceived as more gradual | Choose timing based on your previous response and schedule |
| Duration | Temporary and patient-dependent | Temporary and patient-dependent | Track your own treatment history instead of relying on brand claims |
| Coverage | May suit a broad treatment plan | May suit a more contained treatment plan | The injector should match placement to the muscle and treatment goal |
| Follow-up | Results still require time to assess | Results still require time to assess | Avoid judging the outcome too early |
Diffusion matters most when the treatment area is broad or close to structures that affect brow, eyelid, or mouth movement. A wider pattern may help cover a flat muscle, while a smaller target demands careful mapping and conservative placement. The practical question is not which product has more units. It is whether the injector can place the selected product appropriately for that muscle.
Duration varies with muscle activity, treatment area, dose accuracy, metabolism, and how quickly the patient's movement returns. Strong muscles may require a different plan from mild movement, and a result that feels natural to one patient may feel insufficient to another.
Concentration and dilution also affect how a prepared syringe relates to the intended dose. The volume in the syringe does not independently show the biological effect, so compare the product, units, preparation method, and treatment area together.
For a patient-focused discussion of timing and longevity, read which lasts longer, Botox or Dysport.
Safety and Side-Effect Considerations
Botox and Dysport share the general risks expected from botulinum toxin injections. Temporary bruising, injection-site irritation, headache, mild asymmetry, and unwanted brow or eyelid movement can occur. Rare but serious symptoms require urgent medical attention, particularly difficulty swallowing, speaking, or breathing.
The key product-specific issue is spread in the wrong direction. Dysport's greater diffusion can help treat a broad forehead, but it can be less forgiving near the orbital rim, levator muscle, and corners of the mouth. Unintended spread in those locations may contribute to a heavy brow, eyelid ptosis, or an asymmetric smile. Botox's more localized behavior can support containment, but it doesn't remove the risk.
Questions to bring to the appointment
- Ask about dilution: Find out how the injector prepares the product and how that preparation relates to the planned dose.
- Confirm preparation timing: Ask when the vial was reconstituted and how the clinic handles storage and use.
- Review prior dosing: Bring the product name, treatment areas, approximate units, and your response from previous sessions.
- Discuss areas to avoid: Mention any history of eyelid drooping, brow heaviness, asymmetry, or a previous uneven smile.
- Clarify follow-up: Ask when the clinic evaluates results and how it handles a clinically appropriate touch-up.
Allergic reactions are uncommon with both products. Antibody-mediated resistance is also uncommon at cosmetic doses, but repeated high-dose schedules can raise a different clinical conversation than routine facial treatment. Your medical history, medications, neuromuscular conditions, pregnancy status, and breastfeeding status should be reviewed before treatment.
Pricing Implications of Unit Conversion
A lower Dysport unit price does not necessarily reduce the total treatment cost. With a 2.5:1 conversion, a Botox plan of 20 units corresponds to approximately 50 Dysport units before the injector adjusts for anatomy, concentration, and the intended effect. Compare the cost per treated area, not the raw unit price.
The table uses hypothetical examples at $13 per Botox unit and $5 per Dysport unit, for illustration only, not a clinic quote. The totals show how a conversion can narrow the apparent price difference. Actual fees vary by practice, product, treatment plan, and billing method.
| Treatment Area | Botox Units | Dysport Units | Botox @ $13/unit | Dysport @ $5/unit |
|---|---|---|---|---|
| Glabella example | 20 | 50 | $260 | $250 |
| Forehead example | 10 | 25 | $130 | $125 |
| Crow's feet example, both sides | 12 | 30 | $156 | $150 |
What changes the final bill
Vial size, dilution, minimum-order policies, and whether the clinic charges by unit or area all affect the amount you pay. A clinic may price an entire region because the injector assesses and treats the surrounding anatomy, rather than injecting a fixed number from a syringe. Another practice may charge only for units used, while a third may set a minimum treatment amount.
Read promotional pricing carefully. A low per-unit offer may assume a dose that does not match your muscle strength or treatment goal. Ask for the estimated total units, product name, included treatment areas, and whether follow-up assessment is part of the service.
Use this comparison framework:
- Name the product. Confirm whether the quote is for Botox or Dysport.
- Request the planned dose. Ask for units by area, not only a combined total.
- Compare the same anatomy. A glabella quote is not comparable with a forehead quote.
- Ask about included care. Clarify assessment, follow-up, and touch-up policies.
- Evaluate the expected result. The lowest unit price may not produce the lowest cost for a satisfactory outcome.
For a broader discussion of area-based value, see Botox vs Dysport cost.
Which to Choose and Practitioner FAQs
Dysport often makes sense when the treatment goal involves broader coverage and gradual blending, such as selected forehead patterns. Botox often suits small, precision-sensitive zones, including bunny lines or a lip flip, where limiting spread matters more than covering a wide surface. Those are tendencies, not guarantees. A skilled injector can use either product successfully when the formulation, dose, placement, and anatomy align.
Your treatment history may matter more than the brand. If Botox has given you balanced brows and predictable duration, switching only because Dysport has a lower unit price may not improve the outcome. Conversely, if a patient wants to try a faster-onset product or a broader spread pattern, a carefully planned Dysport session can provide useful personal evidence.
Asymmetric brows and strong glabellar muscles also override generic product preferences. So does a history of eyelid heaviness, an upcoming event, or a previous response that lasted less time than expected. The injector should select the product after examining movement, not before.
Common questions
Are Dysport and Botox results interchangeable?
They can produce similar clinical goals, but their unit systems aren't interchangeable. The injector must translate the treatment plan using product-specific dosing and then adjust for muscle behavior, concentration, and placement.
Can I switch products between treatments?
Many patients can switch at a later appointment, but the decision should be made with the treating clinician. Bring your previous product, units, treatment date, areas treated, and any side effects so the new plan has a reliable reference point.
Should touch-ups be timed differently?
Touch-up timing depends on the product's onset, the injector's assessment, and the degree of correction needed. Don't judge the final result immediately after injection. Follow the clinic's review schedule rather than adding more product because the early appearance seems unchanged.
What should I ask about reconstitution and dilution?
Ask which product was used, how many units are planned in each area, what dilution the clinic uses, and how the injector decides whether the chosen concentration is appropriate for the target muscle. Responsible dosing requires more than a vial label or a low advertised unit price.
For patients comparing devices and skincare alongside injectables, BotoxBarb also offers the Barb N.P. Facial Mask, a wireless LED device designed for comfort on the face with three lighting settings for different treatment goals. It can fit into a broader home-care routine, while Dysport or Botox decisions should remain individualized clinical decisions.
BotoxBarb offers in-clinic Botox and Dysport consultations, along with personalized treatment planning based on your facial anatomy, prior response, and desired level of movement. Visit BotoxBarb to review appointment options and explore medical-grade skincare and LED light therapy products that can complement your aesthetic plan.
